STK11/KEAP1 co-mutations lead to a notable increase in the expression of ferroptosis-protective genes, including SCD and AKR1C1/2/3, as well as resistance to drug-induced ferroptosis in lung cancer cells [26]. The gene discussed is AKR1C1; the disease is lung carcinoma.